GEN Exclusives

More »

Market and Technology Analysis

More »

For full access to this article login to GEN Select now.

Jun 10, 2014

NGS and Cancer Biomarker Market Metrics

Next-generation sequencing is on a growth trajectory.

NGS and Cancer Biomarker Market Metrics

The declining costs of NGS are the key driver for its utilization in the clinical setting. [genome.gov]

  • This report represents qualitative and quantitative metrics of the next-generation sequencing (NGS) landscape and frames it into the context of various biomarker classes.

    Highlights of ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

    • Do not put any letters or characters here if you are not a spy program.
    •  

Get GEN Select Access Now



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?